
Andaman7
Andaman7 is the most advanced decentralized trials platform (aka virtual trials, distributed trials).
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
€1.5k | Support Program | ||
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | - | 14 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Andaman7 is a healthcare technology company that offers a free mobile app designed to transform healthcare communications into Synchronized Health Records. The app allows patients to collect and manage their health data from various sources, including doctors, hospitals, labs, and connected devices, all in one secure place. The company serves a wide range of clients, including patients, healthcare providers, pharmaceutical companies, medical device manufacturers, and research organizations. Operating in the healthcare and clinical trials market, Andaman7's business model revolves around leveraging patients' legal rights to access their health information. The company generates revenue through partnerships with healthcare providers, research organizations, and pharmaceutical companies who benefit from streamlined data collection and communication. By ensuring that health data is easily accessible and securely shared, Andaman7 aims to improve patient outcomes and facilitate faster, more efficient clinical trials.
Keywords: healthcare, mobile app, health records, clinical trials, data security, patient access, healthcare providers, pharmaceutical, research, communication.